NCT02330692

Cohort Study of New Prognostic Factors With Peripheral Blood and Bone Marrow Evaluation at the Time of Diagnosis and Relapse in Myelodysplastic Syndrome

• Status: Unknown
• Phase: —
• Study type: Observational
• Enrollment: 1,000 (estimated)
• Sponsor: Yonsei University · Academic / Other
• Sex: All
• Age: 16 Years
• Healthy volunteers: Not accepted

Summary

Developing a molecular genetic test that can identify prognostic factors which can predict response to treatment, and to contribute to the establishment of future therapeutic strategies base on prognostic factors by undergoing peripheral blood and bone marrow examination of Myelodysplastic Syndrome (MDS) patients at diagnosis and relapse.

Conditions

• Myelodysplastic Syndrome

Interventions

Type	Name	Description
OTHER	No intervention

Timeline

• Start date: 2013-09-01
• Primary completion: 2023-07-01
• Completion: 2023-09-01
• First posted: 2015-01-05
• Last updated: 2019-01-28

Locations

1 site across 1 country: South Korea